Your browser doesn't support javascript.
loading
Chimeric antigen receptor-based therapies beyond cancer.
Velasco-de Andrés, María; Muñoz-Sánchez, Guillermo; Carrillo-Serradell, Laura; Gutiérrez-Hernández, María Del Mar; Català, Cristina; Isamat, Marcos; Lozano, Francisco.
Affiliation
  • Velasco-de Andrés M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Muñoz-Sánchez G; Servei d'Immunologia, Centre de Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Carrillo-Serradell L; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Gutiérrez-Hernández MDM; Servei d'Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Català C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Isamat M; Sepsia Therapeutics S.L., L'Hospitalet de Llobregat, Spain.
  • Lozano F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Eur J Immunol ; 53(3): e2250184, 2023 03.
Article in En | MEDLINE | ID: mdl-36649259

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Eur J Immunol Year: 2023 Document type: Article Affiliation country: Spain Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Eur J Immunol Year: 2023 Document type: Article Affiliation country: Spain Country of publication: Germany